31 results on '"Howie, Jacqueline"'
Search Results
2. Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation.
3. Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase
4. Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies
5. Substrate recognition by the cell surface palmitoyl transferase DHHC5
6. zDHHC5 expression is increased in cardiac hypertrophy and reduced in heart failure but this does not correlate with changes in substrate palmitoylation
7. Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman
8. FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C
9. Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans
10. Dynamic palmitoylation of the sodium-calcium exchanger modulates its structure, affinity for lipid ordered domains, and inhibition by XIP
11. Therapeutic targeting of protein S-acylation for the treatment of disease
12. Therapeutic targeting of protein S-acylation for the treatment of disease.
13. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain
14. Greasing the wheels or a spanner in the works? Regulation of the cardiac sodium pump by palmitoylation
15. Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling
16. An amphipathic α-helix directs palmitoylation of the large intracellular loop of the sodium/calcium exchanger
17. Heart failure leads to altered β 2 -adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
18. A Separate Pool of Cardiac Phospholemman That Does Not Regulate or Associate with the Sodium Pump
19. Regulation of the cardiac Na+ pump by palmitoylation of its catalytic and regulatory subunits
20. Anterior Gradient-3: A novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models
21. The Inhibitory Effect of Phospholemman on the Sodium Pump Requires Its Palmitoylation
22. Phospholemman‐dependent regulation of the cardiac Na/K‐ATPase activity is modulated by inhibitor‐1 sensitive type‐1 phosphatase
23. Global Array-Based Transcriptomics from Minimal Input RNA Utilising an Optimal RNA Isolation Process Combined with SPIA cDNA Probes
24. Phospholemman Recruits Peroxiredoxin 6 to the Cardiac Sodium Pump
25. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
26. Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growthin Vitroandin Vivo
27. Regulation of the cardiac Na+ pump by palmitoylation of its catalytic and regulatory subunits.
28. Dynamic Palmitoylation of the Sodium-Calcium Exchanger Modulates Its Structure, Affinity for Lipid-Ordered Domains, and Inhibition by XIP.
29. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
30. Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling.
31. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.